Position in TRLV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,915,000
New position
Shares Held
500,000
first reported quarter
Ownership
0.260%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#10
of 125 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Verition Fund Management LLC holds $29,871,201 across 13 Drug Manufacturers - Specialty & Generic names. TRLV ranks #3 (16.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
40,988 | $6,908,117 | |
| 2 | ELAN |
Elanco Animal Health Inc
|
250,000 | $6,152,500 | |
| 3 | TRLV |
Trulieve Cannabis Corp.
This page
|
500,000 | $4,915,000 | |
| 4 | LQDA |
Liquidia Corp
|
45,233 | $3,606,427 | |
| 5 | HIMS |
Hims & Hers Health, Inc.
|
97,363 | $3,375,575 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
3,675 | $1,991,225 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
15,000 | $1,664,100 | |
| 8 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
7,500 | $479,625 |
All Filings in TRLV
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,915,000 | 500,000 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||